NRBO neurobopharma.com Kompaniya foydasi

NRBO (NeuroBo Pharmaceuticals, Inc.) - kompaniyaning tovar belgisi

NeuroBo Pharmaceuticals (NRBO) neyrofarmatsevtika segmentini egallash uchun MASH va metabolik buzilishlar bo'yicha davolash portfelini kengtirmoqda. Kompaniyaning foyda hajmi joriy moliyaviy barqarorlikni namoyish etmoqda, bunda ko'rsatkich -0.03 darajasida turibdi. Kelgusidagi daromadlar semizlik terapiyasidagi yangi molekulalarning samaradorligiga bog'liq; biroq, geosiyosiy keskinliklar va sanksiyalar hozirda xalqaro sinovlar hamda biomateriallar logistikasiga to'sqinlik qilmoqda.

Sof daromad: NeuroBo (NRBO) 04.07.2022 - 07.12.2024 uchun

NeuroBo Pharmaceuticals, Inc. (NRBO) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi NeuroBo Pharma|NRBO - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi NeuroBo Pharma|NRBO - Korxona qiymati
- balans kapitallashuvi haqida ma'lumot:
Bitta aksiya hisobiga sof aktivlar qiymati NeuroBo Pharmaceuticals|NRBO - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati neurobopharma.com|NRBO - Kompaniyaning jami aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Barcha qarzlarning o‘z mablag‘lariga nisbati NeuroBo Pharmaceuticals|NRBO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati NeuroBo Pharmaceuticals Inc|NRBO - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati NeuroBo Pharma|NRBO - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz NeuroBo Pharmaceuticals|Oraliq qoplash koeffitsiyenti neurobopharma.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
NRBO - Kompaniyaning sof foydasi
Fundamental baholash:NeuroBo Pharma, NRBO
NeuroBo Pharmaceuticals tomonidan chiqariladigan mahsulotlar

Emitentni tanlashda xatarlarni minimallashtirish uchun umumiy daromadlar va barcha biznes operatsion xarajatlari o'rtasidagi farqni kuzatish juda muhimdir. NeuroBo Pharmaceuticals (NRBO) ning operatsion foydasini tahlil qilish xarajatlarni boshqarish samaradorligini baholash imkonini beradi, bu esa NeuroBo Pharmaceuticals uchun ayniqsa muhimdir, chunki kompaniya neyrodegenerativ patologiyalar va steatogepatitni davolash bo'yicha R&D loyihalarini kengaytirmoqda va bunda yuqori marjalar bankrotlikka qarshi asosiy himoya vositasi bo'lib xizmat qiladi.

Asosiy raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|Kompaniyaning sof foydasi Neurocrine Biosciences|Kompaniya foydasi RGC (regencellbioscience.com)|Sof foyda AXSM|ACAD - Kompaniyaning sof daromadi|Xenon Pharmaceuticals Inc - Sof daromad|Sof foyda Viking Therapeutics Corp VKTX|SUPN - Kompaniyaning sof foydasi|Yakuniy foyda CPRX (catalystpharma.com)|Denali Therapeutics Inc. (DNLI) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Harmony Biosciences Inc (HRMY)|BHVN (Biohaven Pharmaceutical) - Sof foyda|Kompaniyaning sof foydasi AMLX|Kompaniyaning sof foydasi Trevi Therapeutics (TRVI)|PRAX - Kompaniyaning sof daromadi|Anavex Life Sciences Corp. - Sof daromad|Yakuniy foyda CBLL|PRTA - Kompaniyaning sof foydasi|Soliqdan keyingi foyda ALEC|ANNX: Sof foyda|Omeros - Yakuniy foyda|NGNE (Neurogene) - Sof foyda|Sof foyda AC Immune S.A.|Kompaniyaning sof foydasi Voyager Pharma (VYGR)|NMRA (Neumora Corp) - Yakuniy foyda|Kompaniyaning sof foydasi Scilex Holding Company SCLX|TVGN - Sof daromad|Alpha Cognition Corp - Sof foyda|CGTX - Sof foyda|IKT: Sof foyda|Sof daromad Cassava Pharma|ASRT (Assertio Holdings) - Sof foyda|Kompaniyaning sof daromadi Coya COYA|Sof daromad VTGN (Vistagen Therapeutics)|Sof foyda ovidrx.com (OVID)|Acumen Pharma - Sof daromad|Soliqlar to‘langandan keyingi foyda CRVO (CervoMed Corporation)|Alterity Therapeutics Ltd - Sof foyda|Sof moliyaviy natija Clene Inc. CLNN|PEPG: Sof foyda|Sof daromad jupiterneurosciences.com|RLMD (Relmada) - Sof foyda|Sof foyda Annovis Bio Corporation|Kompaniyaning sof foydasi Grace Therapeutics, Inc. (GRCE)|Kompaniyaning sof foydasi AIFF (fireflyneuro.com)|Kompaniyaning sof foydasi Klotho Neurosciences KLTO|Sof moliyaviy natija NeuroSense Therapeutics Ltd (NRSN)|RVPH - Kompaniyaning sof foydasi|MTVA (MetaVia Inc) - Kompaniya foydasi|NeurAxis, Inc. (NRXS) - Kompaniyaning sof foydasi|Helius Medical Technologies - Yakuniy foyda|PASG (Passage Bio Inc.) - Sof foyda|Kompaniyaning sof foydasi NEUP|Kompaniyaning sof foydasi Minerva Neurosciences Corp (NERV)|ATHA - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Addex Therapeutics ADXN|ALZN: Kompaniya foydasi|Cyclerion - Sof foyda|Kompaniyaning sof daromadi Protagenic Therapeutics|KTTA (pasitheaclinics.com) - Sof daromad|Cortigent (CRGT) - Sof foyda|Kompaniyaning sof foydasi Avenue Therapeutics|BCLI: Yakuniy foyda|Kompaniyaning sof foydasi Cara Therapeutics (CARA)|CHRO - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Eliem Therapeutics Inc. ELYM|ITCI: Kompaniya foydasi|Longboard Pharmaceuticals - Sof foyda|Kompaniyaning sof daromadi marinuspharma.com|NKGN (NKGen Biotech) - Sof daromad|Sage Therapeutics Inc. (SAGE) - Sof foyda|Kompaniyaning sof foydasi Neurotrope|TRVN: Yakuniy foyda|Kompaniyaning sof foydasi Vigil Neuroscience (VIGL)|WENA - Kompaniyaning sof daromadi|Sof foyda CERE (Cerevel Therapeutics, Inc.)